Physician profile
Gerald Giurato
NPI 1205837028
$2,226.09
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,259 · 2020: $953 · 2022: $14.21.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $783.50 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $200.80 | 2019-2020 | |
| Amarin Pharma, INC. | $159.70 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $142.34 | 2019-2020 | |
| Glaxosmithkline, LLC. | $136.20 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $119.58 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.41 | 2019-2020 | |
| Pfizer INC. | $86.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $72.55 | 2019 | |
| Astellas Pharma US INC | $50.96 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.05 | 2020 | |
| Allergan, INC. | $46.78 | 2019-2020 | |
| Amgen INC. | $44.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $40.51 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $32.00 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.31 | 2020 | |
| Ironshore Pharmaceuticals INC. | $24.42 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $22.93 | 2019 | |
| Acorda Therapeutics, INC | $16.05 | 2019 | |
| Abbvie INC. | $14.21 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.61 | 2019 | |
| Lilly USA, LLC | $11.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Giurato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.